Together, the differential increase of TIAM1 protein compared with control tissues was consistent with the differential increase of mRNA levels measured in transcriptome Cohorts 1–3 of patients with BPH (Figure 1D). This evidence concerns the gene TIAM1 and benign prostatic hyperplasia.